FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

387032003: Lipase preparation (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2003. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1461210014 Lipase preparation (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1481146017 Lipase preparation en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Lipase preparation Is a Lipase false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing triacylglycerol lipase (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    amylase + lipase + protease 16600 enheder/5000 enheder/18750 enheder kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    amylase + lipase + protease 20000 enheder/4500 enheder/25000 enheder kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    amylase 20000 enheder + lipase 5000 enheder + protease 20000 enheder kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    amylase + lipase + protease 25000 enheder/4000 enheder/25000 enheder kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    amylase + lipase + protease 30000 enheder/10000 enheder/30000 enheder kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    amylase + lipase + protease 30000 enheder/8000 enheder/30000 enheder kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    amylase + lipase + protease 30000 enheder/8000 enheder/30000 enheder tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    amylase + lipase + protease 3000 enheder/2400 enheder/3000 enheder kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    amylase + lipase + protease 33200 enheder/10000 enheder/37500 enheder kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    amylase + lipase + protease 39000 enheder/12000 enheder/39000 enheder kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    amylase + lipase + protease 40000 enheder/8000 enheder/45000 enheder kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    amylase + lipase + protease 48000 enheder/16000 enheder/48000 enheder kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    amylase + lipase + protease 56000 enheder/20000 enheder/44000 enheder kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 58500unt/18000unt/58500unt The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    amylase + lipase + protease 58500 enheder/18000 enheder/58500 enheder kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    amylase + lipase + protease 6000 enheder/16000 enheder/6000 enheder tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    amylase + lipase + protease 65000 enheder/20000 enheder/65000 enheder kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    amylase + lipase + protease 66400 enheder/20000 enheder/75000 enheder kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    amylase + lipase + protease 664400 enheder/20000 enheder/75000 enheder kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    amylase + lipase + protease pulver a 70000 enheder/16800 enheder/70000 enheder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    amylase + lipase + protease 8000 enheder/30000 enheder/30000 enheder tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    amylase + lipase + protease 12000 enheder/4000 enheder/12000 enheder kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    SAME AS association reference set (foundation metadata concept)

    Back to Start